Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Hair oils can worsen seborrheic dermatitis in black patients.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Electrospun matrices help regenerate skin and hair follicles using PCL and collagen scaffolds.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The study found that a specific combination of five medicinal plants effectively inhibits the fungus that causes dandruff.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Collagen networks play a key role in hair loss and follicle miniaturization.

Precision medicine is crucial for early diagnosis and personalized treatment in prediabetes.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Bhangra may help treat premature greying of hair by boosting melanin and improving scalp health.

Hair follicles can be used to study gene expression and understand conditions like COPD.

Upadacitinib effectively treats severe alopecia areata and is safe.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.